#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Lip and/or oral cavity cancer Congenital absence of bile ducts Indolent systemic mastocytosis Progressive multifocal leukoencephalopathy Immune-mediated enterocolitis Adenovirus infection Autoimmune myositis Oesophageal adenocarcinoma stage III Retinopathy proliferative Neuropathy peripheral Neuroendocrine carcinoma metastatic Paraganglion neoplasm Squamous cell carcinoma of the vulva Colon cancer Transferrin decreased More trials…

    Learn about Rare Diseases

    X-linked lymphoproliferative syndrome – Trials in Disease Niemann-Pick disease – Diagnostics Loeys-Dietz syndrome – Basic Information Cholangitis sclerosing – Treatment Short-bowel syndrome – Basic Information Cystic fibrosis lung – Treatment Retinoblastoma – Life with Disease Pleomorphic leiomyosarcoma – Trials in Disease Adrenocortical carcinoma – Trials in Disease Primary biliary cholangitis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gskvx000000014593 Daunorubicin Hydrochloride Luspatercept Risedronate Sodium Posaconazole Azathioprine Arachis Hypogaea Flour Disitamab Vedotin Poloxamer 407 Pyridoxine Hydrochloride Obicetrapib Ciltacabtagene Autoleucel Hypothalamic Phospholipids Sodium Iodide (131I) Bimekizumab REGN7999 Elranatamab FLUORIDE Vinorelbine Atl001 More therapies…

    Learn about Your Condition

    Hidradenitis Post cardiac arrest syndrome Chronic coronary syndrome Skin cancer Tympanic membrane perforation Phenylketonuria Prostate cancer Type IIa hyperlipidaemia Immunodeficiency Hepatobiliary disease Ovarian cancer stage III Arteriosclerosis Sciatica Retinal vein occlusion Anal fissure More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Evaluating the efficacy of pirtobrutinib and epcoritamab in patients with untreated Richter transformation of chronic lymphocytic leukemia

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Vincristine
    • Cyclophosphamide
    • Doxorubicin Hydrochloride
    Austria Denmark Germany Ireland

  • A study to evaluate the effectiveness and safety of REGN13335 in adults with pulmonary arterial hypertension

    Recruiting

    2 1
    Investigated Drugs:
    • HUMAN IGG4 KAPPA MONOCLONAL ANTIBODY AGAINST PLATELET-DERIVED GROWTH FACTOR SUBUNIT B
    Belgium Czechia France Germany Latvia Poland +1

  • A study of RPTR-1-201 and pembrolizumab in patients with advanced solid tumors

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • RPTR-1-201
    • Pembrolizumab
    France Ireland Portugal Spain

  • Study to evaluate the efficacy and safety of deucrictibant for the prevention and treatment of angioedema attacks in adults with acquired angioedema

    Recruiting

    3 1
    Investigated Drugs:
    • Deucrictibant
    Austria Bulgaria France Germany Hungary Italy +3

  • A study to evaluate the effects of BI 764198 in adults and adolescents with focal segmental glomerulosclerosis (FSGS)

    Recruiting

    3 1
    Investigated Drugs:
    • [4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone
    Belgium Croatia Denmark France Germany Greece +9

  • A study of YL201 and atezolizumab for patients with advanced solid tumors

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • YL201
    • Atezolizumab
    Belgium France Germany Hungary Italy Poland +2
Previous Page
1 … 42 43 44 45 46 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!